Delphi has been legal advisor to Navamedic ASA (”Navamedic”), a company listed on the Oslo Stock Exchange, in the acquisition of the Swedish medical device company Observe Medical International AB (”OM”) from a group of investors led by the Danish venture fund Seed Capital and the founders of OM. The initial purchase price is NOK 35 million, of which NOK 20 million shall be paid in cash and NOK 10 million will be paid through the issue of new Navamedic shares. In addition, there is a possibility to receive certain milestone payments and royalties.
Delphi’s team was led by Fredrik Mörner, senior associate, mainly supported by Erika Hammar, associate but also by Rickard Isacson, senior associate, Elisabeth Eklund, partner and Göran Karlsson, partner.
For more information, see Navamedic’s press release www.navamedic.com.
Ph. +46 767 72 00 04
Delphi is one of the top commercial law firms in Sweden. We help our clients with mergers and acquisitions. We advise them on matters of banking, finance and capital markets. We represent clients in court and in arbitration and are acknowledged as being extremely competent in public procurement, environmental law and real estate law.
Many of us are specialists in high-tech fields such as IT, intellectual property and life science. Our drive and our interest in technology and business probably explain, in part, our success. We are often praised for our commercial sense and our ability to understand the client’s business.
Our clients are to be found primarily in Scandinavia, Europe and North America. We also co-operate with law firms globally and regularly assist clients on international matters. We have a total workforce of approximately 185, of which more than 120 are lawyers. We have offices in Stockholm, Göteborg, Malmö, Linköping and Norrköping.